The global Anti-depressant Drugs market was valued at US$ 12230 million in 2023 and is anticipated to reach US$ 13890 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.

Anti-depressant Drugs Market

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anti-depressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-depressant Drugs.

Report Scope

The Anti-depressant Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-depressant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-depressant Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Anti-depressant Drugs Market Report

Report Metric	Details
Report Name	Anti-depressant Drugs Market
Accounted market size in 2023	US$ 12230 million
Forecasted market size in 2030	US$ 13890 million
CAGR	2.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Selective Serotonin Reuptake Inhibitor (SSRI) Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Tricyclic Antidepressant (TCA) Monoamine Oxidase Inhibitor (MAOI) Others
Segment by Application	Major Depressive Disorder Obsessive-Compulsive Disorder Generalized Anxiety Disorder Panic Disorder Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer, Teva Pharmaceutical Industries, Takeda Pharmaceutical Company, AstraZeneca, Johnson and Johnson, Sanofi, Sun Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-depressant Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-depressant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-depressant Drugs Market growing?

Ans: The Anti-depressant Drugs Market witnessing a CAGR of 2.6% during the forecast period 2024-2030.

What is the Anti-depressant Drugs Market size in 2030?

Ans: The Anti-depressant Drugs Market size in 2030 will be US$ 13890 million.

Who are the main players in the Anti-depressant Drugs Market report?

Ans: The main players in the Anti-depressant Drugs Market are Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer, Teva Pharmaceutical Industries, Takeda Pharmaceutical Company, AstraZeneca, Johnson and Johnson, Sanofi, Sun Pharmaceuticals

What are the Application segmentation covered in the Anti-depressant Drugs Market report?

Ans: The Applications covered in the Anti-depressant Drugs Market report are Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others

What are the Type segmentation covered in the Anti-depressant Drugs Market report?

Ans: The Types covered in the Anti-depressant Drugs Market report are Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI), Others

1 Anti-depressant Drugs Market Overview

1.1 Product Overview and Scope of Anti-depressant Drugs

1.2 Anti-depressant Drugs Segment by Type

1.2.1 Global Anti-depressant Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI)

1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

1.2.4 Tricyclic Antidepressant (TCA)

1.2.5 Monoamine Oxidase Inhibitor (MAOI)

1.2.6 Others

1.3 Anti-depressant Drugs Segment by Application

1.3.1 Global Anti-depressant Drugs Market Value by Application: (2024-2030)

1.3.2 Major Depressive Disorder

1.3.3 Obsessive-Compulsive Disorder

1.3.4 Generalized Anxiety Disorder

1.3.5 Panic Disorder

1.3.6 Others

1.4 Global Anti-depressant Drugs Market Size Estimates and Forecasts

1.4.1 Global Anti-depressant Drugs Revenue 2019-2030

1.4.2 Global Anti-depressant Drugs Sales 2019-2030

1.4.3 Global Anti-depressant Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Anti-depressant Drugs Market Competition by Manufacturers

2.1 Global Anti-depressant Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Anti-depressant Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Anti-depressant Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Anti-depressant Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anti-depressant Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anti-depressant Drugs, Product Type & Application

2.7 Anti-depressant Drugs Market Competitive Situation and Trends

2.7.1 Anti-depressant Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Anti-depressant Drugs Players Market Share by Revenue

2.7.3 Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-depressant Drugs Retrospective Market Scenario by Region

3.1 Global Anti-depressant Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Anti-depressant Drugs Global Anti-depressant Drugs Sales by Region: 2019-2030

3.2.1 Global Anti-depressant Drugs Sales by Region: 2019-2024

3.2.2 Global Anti-depressant Drugs Sales by Region: 2025-2030

3.3 Global Anti-depressant Drugs Global Anti-depressant Drugs Revenue by Region: 2019-2030

3.3.1 Global Anti-depressant Drugs Revenue by Region: 2019-2024

3.3.2 Global Anti-depressant Drugs Revenue by Region: 2025-2030

3.4 North America Anti-depressant Drugs Market Facts & Figures by Country

3.4.1 North America Anti-depressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Anti-depressant Drugs Sales by Country (2019-2030)

3.4.3 North America Anti-depressant Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Anti-depressant Drugs Market Facts & Figures by Country

3.5.1 Europe Anti-depressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Anti-depressant Drugs Sales by Country (2019-2030)

3.5.3 Europe Anti-depressant Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anti-depressant Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Anti-depressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Anti-depressant Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Anti-depressant Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Anti-depressant Drugs Market Facts & Figures by Country

3.7.1 Latin America Anti-depressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Anti-depressant Drugs Sales by Country (2019-2030)

3.7.3 Latin America Anti-depressant Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anti-depressant Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Anti-depressant Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Anti-depressant Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Anti-depressant Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Anti-depressant Drugs Sales by Type (2019-2030)

4.1.1 Global Anti-depressant Drugs Sales by Type (2019-2024)

4.1.2 Global Anti-depressant Drugs Sales by Type (2025-2030)

4.1.3 Global Anti-depressant Drugs Sales Market Share by Type (2019-2030)

4.2 Global Anti-depressant Drugs Revenue by Type (2019-2030)

4.2.1 Global Anti-depressant Drugs Revenue by Type (2019-2024)

4.2.2 Global Anti-depressant Drugs Revenue by Type (2025-2030)

4.2.3 Global Anti-depressant Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Anti-depressant Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Anti-depressant Drugs Sales by Application (2019-2030)

5.1.1 Global Anti-depressant Drugs Sales by Application (2019-2024)

5.1.2 Global Anti-depressant Drugs Sales by Application (2025-2030)

5.1.3 Global Anti-depressant Drugs Sales Market Share by Application (2019-2030)

5.2 Global Anti-depressant Drugs Revenue by Application (2019-2030)

5.2.1 Global Anti-depressant Drugs Revenue by Application (2019-2024)

5.2.2 Global Anti-depressant Drugs Revenue by Application (2025-2030)

5.2.3 Global Anti-depressant Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Anti-depressant Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Alkermes

6.1.1 Alkermes Corporation Information

6.1.2 Alkermes Description and Business Overview

6.1.3 Alkermes Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Alkermes Anti-depressant Drugs Product Portfolio

6.1.5 Alkermes Recent Developments/Updates

6.2 Allergan

6.2.1 Allergan Corporation Information

6.2.2 Allergan Description and Business Overview

6.2.3 Allergan Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Allergan Anti-depressant Drugs Product Portfolio

6.2.5 Allergan Recent Developments/Updates

6.3 Bristol-Myers Squibb

6.3.1 Bristol-Myers Squibb Corporation Information

6.3.2 Bristol-Myers Squibb Description and Business Overview

6.3.3 Bristol-Myers Squibb Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bristol-Myers Squibb Anti-depressant Drugs Product Portfolio

6.3.5 Bristol-Myers Squibb Recent Developments/Updates

6.4 Eli Lilly and Company

6.4.1 Eli Lilly and Company Corporation Information

6.4.2 Eli Lilly and Company Description and Business Overview

6.4.3 Eli Lilly and Company Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Eli Lilly and Company Anti-depressant Drugs Product Portfolio

6.4.5 Eli Lilly and Company Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Anti-depressant Drugs Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Lundbeck

6.6.1 Lundbeck Corporation Information

6.6.2 Lundbeck Description and Business Overview

6.6.3 Lundbeck Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Lundbeck Anti-depressant Drugs Product Portfolio

6.6.5 Lundbeck Recent Developments/Updates

6.7 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Anti-depressant Drugs Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Pfizer

6.8.1 Pfizer Corporation Information

6.8.2 Pfizer Description and Business Overview

6.8.3 Pfizer Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Pfizer Anti-depressant Drugs Product Portfolio

6.8.5 Pfizer Recent Developments/Updates

6.9 Teva Pharmaceutical Industries

6.9.1 Teva Pharmaceutical Industries Corporation Information

6.9.2 Teva Pharmaceutical Industries Description and Business Overview

6.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Product Portfolio

6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.10 Takeda Pharmaceutical Company

6.10.1 Takeda Pharmaceutical Company Corporation Information

6.10.2 Takeda Pharmaceutical Company Description and Business Overview

6.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Product Portfolio

6.10.5 Takeda Pharmaceutical Company Recent Developments/Updates

6.11 AstraZeneca

6.11.1 AstraZeneca Corporation Information

6.11.2 AstraZeneca Anti-depressant Drugs Description and Business Overview

6.11.3 AstraZeneca Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 AstraZeneca Anti-depressant Drugs Product Portfolio

6.11.5 AstraZeneca Recent Developments/Updates

6.12 Johnson and Johnson

6.12.1 Johnson and Johnson Corporation Information

6.12.2 Johnson and Johnson Anti-depressant Drugs Description and Business Overview

6.12.3 Johnson and Johnson Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Johnson and Johnson Anti-depressant Drugs Product Portfolio

6.12.5 Johnson and Johnson Recent Developments/Updates

6.13 Sanofi

6.13.1 Sanofi Corporation Information

6.13.2 Sanofi Anti-depressant Drugs Description and Business Overview

6.13.3 Sanofi Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Sanofi Anti-depressant Drugs Product Portfolio

6.13.5 Sanofi Recent Developments/Updates

6.14 Sun Pharmaceuticals

6.14.1 Sun Pharmaceuticals Corporation Information

6.14.2 Sun Pharmaceuticals Anti-depressant Drugs Description and Business Overview

6.14.3 Sun Pharmaceuticals Anti-depressant Drugs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Sun Pharmaceuticals Anti-depressant Drugs Product Portfolio

6.14.5 Sun Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anti-depressant Drugs Industry Chain Analysis

7.2 Anti-depressant Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anti-depressant Drugs Production Mode & Process

7.4 Anti-depressant Drugs Sales and Marketing

7.4.1 Anti-depressant Drugs Sales Channels

7.4.2 Anti-depressant Drugs Distributors

7.5 Anti-depressant Drugs Customers

8 Anti-depressant Drugs Market Dynamics

8.1 Anti-depressant Drugs Industry Trends

8.2 Anti-depressant Drugs Market Drivers

8.3 Anti-depressant Drugs Market Challenges

8.4 Anti-depressant Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alkermes plc

Allergan plc

Bristol–Myers Squibb

Eli Lilly and Company

Teva Pharmaceutical Industries

Takeda Pharmaceutical Company

List of Tables

Table 1. Global Anti-depressant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Anti-depressant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Anti-depressant Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Anti-depressant Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Anti-depressant Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Anti-depressant Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Anti-depressant Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Anti-depressant Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Anti-depressant Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anti-depressant Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anti-depressant Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Anti-depressant Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-depressant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-depressant Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-depressant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Anti-depressant Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Anti-depressant Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Anti-depressant Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Anti-depressant Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Anti-depressant Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Anti-depressant Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Anti-depressant Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Anti-depressant Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Anti-depressant Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Anti-depressant Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Anti-depressant Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Anti-depressant Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Anti-depressant Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Anti-depressant Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Anti-depressant Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Anti-depressant Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Anti-depressant Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Anti-depressant Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Anti-depressant Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Anti-depressant Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Anti-depressant Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Anti-depressant Drugs Price (USD/Unit) by Type (2019-2024)

Table 59. Global Anti-depressant Drugs Price (USD/Unit) by Type (2025-2030)

Table 60. Global Anti-depressant Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Anti-depressant Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Anti-depressant Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Anti-depressant Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Anti-depressant Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Anti-depressant Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Anti-depressant Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Anti-depressant Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Anti-depressant Drugs Price (USD/Unit) by Application (2019-2024)

Table 69. Global Anti-depressant Drugs Price (USD/Unit) by Application (2025-2030)

Table 70. Alkermes Corporation Information

Table 71. Alkermes Description and Business Overview

Table 72. Alkermes Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Alkermes Anti-depressant Drugs Product

Table 74. Alkermes Recent Developments/Updates

Table 75. Allergan Corporation Information

Table 76. Allergan Description and Business Overview

Table 77. Allergan Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Allergan Anti-depressant Drugs Product

Table 79. Allergan Recent Developments/Updates

Table 80. Bristol-Myers Squibb Corporation Information

Table 81. Bristol-Myers Squibb Description and Business Overview

Table 82. Bristol-Myers Squibb Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Bristol-Myers Squibb Anti-depressant Drugs Product

Table 84. Bristol-Myers Squibb Recent Developments/Updates

Table 85. Eli Lilly and Company Corporation Information

Table 86. Eli Lilly and Company Description and Business Overview

Table 87. Eli Lilly and Company Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Eli Lilly and Company Anti-depressant Drugs Product

Table 89. Eli Lilly and Company Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Anti-depressant Drugs Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Lundbeck Corporation Information

Table 96. Lundbeck Description and Business Overview

Table 97. Lundbeck Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Lundbeck Anti-depressant Drugs Product

Table 99. Lundbeck Recent Developments/Updates

Table 100. Merck Corporation Information

Table 101. Merck Description and Business Overview

Table 102. Merck Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Merck Anti-depressant Drugs Product

Table 104. Merck Recent Developments/Updates

Table 105. Pfizer Corporation Information

Table 106. Pfizer Description and Business Overview

Table 107. Pfizer Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Pfizer Anti-depressant Drugs Product

Table 109. Pfizer Recent Developments/Updates

Table 110. Teva Pharmaceutical Industries Corporation Information

Table 111. Teva Pharmaceutical Industries Description and Business Overview

Table 112. Teva Pharmaceutical Industries Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Teva Pharmaceutical Industries Anti-depressant Drugs Product

Table 114. Teva Pharmaceutical Industries Recent Developments/Updates

Table 115. Takeda Pharmaceutical Company Corporation Information

Table 116. Takeda Pharmaceutical Company Description and Business Overview

Table 117. Takeda Pharmaceutical Company Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Takeda Pharmaceutical Company Anti-depressant Drugs Product

Table 119. Takeda Pharmaceutical Company Recent Developments/Updates

Table 120. AstraZeneca Corporation Information

Table 121. AstraZeneca Description and Business Overview

Table 122. AstraZeneca Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. AstraZeneca Anti-depressant Drugs Product

Table 124. AstraZeneca Recent Developments/Updates

Table 125. Johnson and Johnson Corporation Information

Table 126. Johnson and Johnson Description and Business Overview

Table 127. Johnson and Johnson Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Johnson and Johnson Anti-depressant Drugs Product

Table 129. Johnson and Johnson Recent Developments/Updates

Table 130. Sanofi Corporation Information

Table 131. Sanofi Description and Business Overview

Table 132. Sanofi Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Sanofi Anti-depressant Drugs Product

Table 134. Sanofi Recent Developments/Updates

Table 135. Sun Pharmaceuticals Corporation Information

Table 136. Sun Pharmaceuticals Description and Business Overview

Table 137. Sun Pharmaceuticals Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Sun Pharmaceuticals Anti-depressant Drugs Product

Table 139. Sun Pharmaceuticals Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Anti-depressant Drugs Distributors List

Table 143. Anti-depressant Drugs Customers List

Table 144. Anti-depressant Drugs Market Trends

Table 145. Anti-depressant Drugs Market Drivers

Table 146. Anti-depressant Drugs Market Challenges

Table 147. Anti-depressant Drugs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Anti-depressant Drugs

Figure 2. Global Anti-depressant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Anti-depressant Drugs Market Share by Type in 2023 & 2030

Figure 4. Selective Serotonin Reuptake Inhibitor (SSRI) Product Picture

Figure 5. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Product Picture

Figure 6. Tricyclic Antidepressant (TCA) Product Picture

Figure 7. Monoamine Oxidase Inhibitor (MAOI) Product Picture

Figure 8. Others Product Picture

Figure 9. Global Anti-depressant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Anti-depressant Drugs Market Share by Application in 2023 & 2030

Figure 11. Major Depressive Disorder

Figure 12. Obsessive-Compulsive Disorder

Figure 13. Generalized Anxiety Disorder

Figure 14. Panic Disorder

Figure 15. Others

Figure 16. Global Anti-depressant Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Anti-depressant Drugs Market Size (2019-2030) & (US$ Million)

Figure 18. Global Anti-depressant Drugs Sales (2019-2030) & (K Units)

Figure 19. Global Anti-depressant Drugs Average Price (USD/Unit) & (2019-2030)

Figure 20. Anti-depressant Drugs Report Years Considered

Figure 21. Anti-depressant Drugs Sales Share by Manufacturers in 2023

Figure 22. Global Anti-depressant Drugs Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Anti-depressant Drugs Players: Market Share by Revenue in 2023

Figure 24. Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Anti-depressant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Anti-depressant Drugs Sales Market Share by Country (2019-2030)

Figure 27. North America Anti-depressant Drugs Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Anti-depressant Drugs Sales Market Share by Country (2019-2030)

Figure 31. Europe Anti-depressant Drugs Revenue Market Share by Country (2019-2030)

Figure 32. Germany Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Anti-depressant Drugs Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Anti-depressant Drugs Revenue Market Share by Region (2019-2030)

Figure 39. China Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Anti-depressant Drugs Sales Market Share by Country (2019-2030)

Figure 50. Latin America Anti-depressant Drugs Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Anti-depressant Drugs Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Anti-depressant Drugs Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. U.A.E Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Anti-depressant Drugs by Type (2019-2030)

Figure 60. Global Revenue Market Share of Anti-depressant Drugs by Type (2019-2030)

Figure 61. Global Anti-depressant Drugs Price (USD/Unit) by Type (2019-2030)

Figure 62. Global Sales Market Share of Anti-depressant Drugs by Application (2019-2030)

Figure 63. Global Revenue Market Share of Anti-depressant Drugs by Application (2019-2030)

Figure 64. Global Anti-depressant Drugs Price (USD/Unit) by Application (2019-2030)

Figure 65. Anti-depressant Drugs Value Chain

Figure 66. Anti-depressant Drugs Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions